AMPEL BioSolutions

Solutions for the Next Generation of Novel Therapies. AMPEL BioSolutions is dedicated to finding the right drug for the right patient at the right time. We are a multifaceted biomedical company utilizing both data and clinical science to facilitate drug target identification and validation. Together, our team has the tools and expertise - a global understanding of the biomedical field, basic/clinical research, medicine, and risk management - to creatively and efficiently bring specific and effective solutions to the most challenging research, discovery, and developmental problems

Clinical trials,bioinformatics,autoimmunity,inflammation,drug repositioning,immunology,systemic lupus erythematosus (sle),autoimmune and inflammatory diseases,disease biomarker identification,data analysis and interpretation,clinical trial design and management,target identification and validation,rheumatology,and gout

Ampel biosolutions operates in the Biotechnology research industry.

Ampel biosolutions's revenue is 11m - 100m

Ampel biosolutions has 11 - 50 employees.